StemCells, Inc. Announces First Patient Cohort Completes Spinal Cord Injury Trial – Gains in Sensory Function Persist 12 Months After Stem Cell Transplant
[at noodls] – Improvement From Complete to Incomplete Injury Observed in One Patient NEWARK, Calif., Feb. 12, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) today announced that the twelve-month data from the … more
View todays social media effects on STEM
View the latest stocks trending across Twitter. Click to view dashboard
See who StemCells is hiring next, click here to view
